The National Pharmaceuticals Strategy: Rest in peace, revive or renew?
作者信息
MacKinnon Neil J, Ip Ivan
出版信息
CMAJ. 2009 Apr 14;180(8):801-3. doi: 10.1503/cmaj.082087. Epub 2009 Feb 3.
Abstract
摘要
相似文献
1
The National Pharmaceuticals Strategy: Rest in peace, revive or renew?
CMAJ. 2009 Apr 14;180(8):801-3. doi: 10.1503/cmaj.082087. Epub 2009 Feb 3.
2
Americans' access to prescription drugs stabilizes, 2007-2010.
Track Rep. 2011 Dec(27):1-5.
3
Will lower drug prices jeopardize drug research? A policy fact sheet.
Am J Bioeth. 2004 Winter;4(1):W1-4. doi: 10.1162/152651604773067488.
4
Burden of prescription drug costs in the United States.
J Manag Care Pharm. 2003 Jan-Feb;9(1):91-2. doi: 10.18553/jmcp.2003.9.1.91.
5
Value-Based Pricing and Patient Access for Specialty Drugs.
JAMA. 2018 Jun 5;319(21):2169-2170. doi: 10.1001/jama.2018.5367.
6
Pharmacoeconomics: basic concepts and terminology.
Br J Clin Pharmacol. 1997 Apr;43(4):343-8. doi: 10.1046/j.1365-2125.1997.00574.x.
7
Association Between Narrow Pharmacy Networks and Medication Adherence.
JAMA Intern Med. 2015 Nov;175(11):1850-3. doi: 10.1001/jamainternmed.2015.4582.
8
Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.
BMJ. 2018 May 17;361:k1039. doi: 10.1136/bmj.k1039.
9
Prior authorization to manage drug utilization and costs.
J Manag Care Pharm. 2003 Jan-Feb;9(1):95. doi: 10.18553/jmcp.2003.9.1.95a.
10
[Scope of the contract for drug therapy. Rebate contracts also for original drugs].
MMW Fortschr Med. 2009 Jul 23;151(30-33):80.
引用本文的文献
1
Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies.
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):8-25. doi: 10.1002/pds.4738. Epub 2019 Feb 20.
2
[Assurance-médicaments nationale: Le moment d'aller de l'avant].
Can Fam Physician. 2016 Jul;62(7):e361-3.
3
National pharmacare: Time to move forward.
Can Fam Physician. 2016 Jul;62(7):544-6.
4
Addressing the authorization of orphan drugs will not fix reimbursement problems: The elephant is still in the room.
Can Pharm J (Ott). 2013 Sep;146(5):245-6. doi: 10.1177/1715163513499127.
本文引用的文献
1
In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008.
Health Aff (Millwood). 2009 Jan-Feb;28(1):w1-16. doi: 10.1377/hlthaff.28.1.w1. Epub 2008 Nov 13.
2
Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.
CMAJ. 2008 Jun 3;178(12):1563-9. doi: 10.1503/cmaj.071594.
3
Toward higher-performance health systems: adults' health care experiences in seven countries, 2007.
Health Aff (Millwood). 2007 Nov-Dec;26(6):w717-34. doi: 10.1377/hlthaff.26.6.w717.
4
On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries.
Health Aff (Millwood). 2006 Nov-Dec;25(6):w555-71. doi: 10.1377/hlthaff.25.w555. Epub 2006 Nov 2.
5
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada.
CMAJ. 2004 May 25;170(11):1678-86. doi: 10.1503/cmaj.1040498.
Zotero 插件